News
Unlike cervical cancer, endometrial cancer often presents with symptoms at an early stage, per the Mayo Clinic, resulting in ...
Loni Anderson’s cause of death has been confirmed as a rare and aggressive form of uterine cancer that occurs in just 6 out ...
Endometrial cancer usually returns within three years after treatment. Most of the studies that looked at recurrence rates lasted less than five years, so it's hard to know exactly how many ...
12h
TipRanks on MSNAstraZeneca’s DESTINY-Endometrial01: A New Frontier in Endometrial Cancer Treatment
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: The DESTINY-Endometrial01 study aims to evaluate the ...
The treatment combines pembrolizumab, made by Merck Sharp & Dohme, with chemotherapy drugs carboplatin and paclitaxel. Pembrolizumab is an immunotherapy that helps the immune system recognise and ...
3d
MedPage Today on MSNGood News on GLP-1s and Cancer Risk, With One Exception
GLP-1 agonist users had a 17% lower cancer risk compared to non-users in a large retrospective study. The reductions achieved ...
People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer ...
Women with advanced form womb cancer have been given fresh hope after a new treatment was given the green light for ...
Understanding Obesity and Endometrial Cancer Risk: Opportunities for Prevention Schmandt RE, Iglesias DA, Co NN, Lu KH Am J Obstet Gynecol. 2011;205:518-525 ...
2d
News-Medical.Net on MSNResearchers identify molecular mechanism behind tamoxifen-related uterine cancer
In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...
Karen’s work raising thousands for Cancer Research UK feels more poignant than ever for their family, after Tania was ...
An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results